Study S001696
HRS-7535-202 Follow-up Study: A Long-term Evaluation of Safety, Tolerability, and Efficacy in Obese Subjects (Open-label, Extension Trial)
Registration
Registered primary outcomes
- Number of participants with Treatment-emergent Adverse Event(AE) [During the 32-week open-label extension treatment period]
Linked records (0)
Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.
No records link to this registration yet.